Morinaga BB536® - Japan’s Top-Selling Clinically Proven Probiotic
In breastfed infants, an astonishing 90% of the bacterial colonies in the GI tract are made up of bifidobacteria. As we age, the presence of Bifidobacterium longum in particular drops precipitously leaving only an average of 5% of the original colonies in an adult intestinal tract. Since it is often replaced with harmful bacteria such as E.coli, the case for nutritional supplementation with bifidobacterium longum is strong.
But not all strains within this species are created equal. Morinaga BB536 is supported by 40 human clinical studies showing a range of benefits for digestive support, immunity, healthy response to seasonal challenges and infant health. BB536 also offers unparalleled stability, showing 80% active cell counts after 48 months at room temperature.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.